Carcinogenicity evaluation: Comparison of tumor data from dual control groups in the Sprague-Dawley rat

被引:30
作者
Baldrick, P [1 ]
机构
[1] Covance Labs Ltd, Sci & Regulatory Consulting, Harrogate HG3 1PY, N Yorkshire, England
关键词
Sprague-Dawley rat; benign and malignant neoplasms; carcinogenicity; survival; dual control groups; genetic drift;
D O I
10.1080/019262390908371
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Following recent clarification in Europe that a single control group is now acceptable for rodent carcinogenicity studies, the use of dual controls may be reduced or disappear. To date, virtually nothing has been published on whether this latter situation has improved the identification of tumorigenic risk potential in these studies. In this paper, the results of 13 rat carcinogenicity studies, performed between 1991 and 2002, with 2 control groups, are presented. Although no major differences in tumor incidences between these dual control groups were found, some interstudy variation occurred. In cases where a notable difference was seen, the use of 2 control groups, as well as robust, contemporary background data, allowed an easier interpretation of findings in drug-treated groups. Thus, the continued use of dual control groups has a vital role in the assessment of tumoriogenic risk. The paper also presents an update on survival, on the range and extent of background spontaneous neoplasms, and comments on genetic drift in this commonly used rat strain.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 30 条
[1]  
[Anonymous], 1998, S1B ICH
[2]   Neoplastic and non-neoplastic lesions in the mammary gland, endocrine and genital organs in aging male and female Sprague-Dawley rats [J].
Attia, MA .
ARCHIVES OF TOXICOLOGY, 1996, 70 (08) :461-473
[3]  
Britton L.D., 2004, TOXICOL SCI, V78, P560
[4]  
*CDER, 2001, IN PRESS GUID IND ST
[5]   SPONTANEOUS NEOPLASMS IN AGED SPRAGUE-DAWLEY RATS [J].
CHANDRA, M ;
RILEY, MGI ;
JOHNSON, DE .
ARCHIVES OF TOXICOLOGY, 1992, 66 (07) :496-502
[6]   Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals [J].
Contrera, JF ;
Jacobs, AC ;
DeGeorge, JJ .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 25 (02) :130-145
[7]  
*CPMP SWP, 2003, CPMPSWP287700
[8]  
Fairweather WR, 1998, DRUG INF J, V32, P401, DOI 10.1177/009286159803200212
[9]   SPONTANEOUS TUMOR RATES - THEIR USE TO SUPPORT RODENT BIOASSAYS [J].
GOPINATH, C .
TOXICOLOGIC PATHOLOGY, 1994, 22 (02) :160-164
[10]   Evaluation of historical control data in carcinogenicity studies [J].
Greim, H ;
Gelbke, HP ;
Reuter, U ;
Thielmann, HW ;
Edler, L .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2003, 22 (10) :541-549